`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Trials@uspto.gov
`571-272-7822
`
`Paper No. 7
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`TEVA PHARMACEUTICALS USA, INC.,
`Petitioner,
`
`v.
`
`CORCEPT THERAPEUTICS, INC.,
`Patent Owner.
`
`Case PGR2019-00048
`Patent 10,195,214
`
`Mailed: May 30, 2019
`
`Before Esther Goldschlager, Trial Paralegal
`
`NOTICE OF ACCEPTING CORRECTED EXHIBIT
`
`The corrected exhibit filed on May 28, 2019 in the above proceeding is
`accepted.
`The parties are reminded that unless otherwise permitted by 37 C.F.R.
`§ 42.6(b)(2), all filings in this proceeding must be made electronically in the
`Patent Trial and Appeal Board End to End (PTAB E2E), accessible from the
`Board Web site at http://www.uspto.gov/PTAB. To file documents, users
`must first obtain a user ID and password by registering with PTAB E2E.
`
`
`
`PGR2019-00048
`Patent 10,195,214
`
`
`
`Information regarding how to register with and use PTAB E2E is available
`at the Board Web site.
`If there are any questions pertaining to this notice, please contact
`Esther Goldschlager at (571) 270-5960 or the Patent Trial and Appeal Board
`at 571-272-7822.
`
`
`
`
`For PETITIONER:
`Deborah Sterling
`Olga Partington
`STERNE KESSLER GOLDSTEIN & FOX PLLC
`dsterling-ptab@sternekessler.com
`opartington-ptab@sternekessler.com
`
`For PATENT OWNER:
`Francis Cerrito
`Frank Calvosa
`QUINN EMANUEL URQUHART & SULLIVAN, LLP
`nickcerrito@quinnemanuel.com
`frankcalvosa@quinnemanuel.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`